#Netherlands #Veldhoven #CooperVision #MyDay #MiSight

CooperVision at NCC 2026: Pioneering Comfort in Contact Lenses

The upcoming Netherlands Contact Lens Congress (NCC) 2026 is set to feature a significant presentation by CooperVision, a leader in contact lens innovation. Taking place on March 8th and 9th in Veldhoven, Netherlands, this event will highlight several scientific articles and posters that underscore the importance of evidence-based approaches in enhancing the comfort and clarity of contact lenses.

CooperVision’s initiative aims to show how continuous innovation in lens design meets the evolving visual needs of consumers across all stages of life. "Our goal at CooperVision is to continually improve the way people see by advancing contact lens designs and modalities that adapt to their visual requirements," stated Marcella McParland, CooperVision’s Senior Director of Professional Affairs for EMEA.

Research Highlights

One of the standout studies to be presented focuses on the transition from traditional single-vision contact lenses to the dual-focus design of MiSight® 1 Day, aimed at myopia management. Remarkably, the study finds that young adults experience similar vision quality and comfort levels within a six-month adaptation period. This highlights the necessity for eye care professionals to effectively manage patient expectations regarding comfort and vision quality during their adjustment phase.

Additionally, CooperVision will introduce a broader study validating that contemporary spherical contact lens designs, including popular brands like MyDay® and Biofinity®, fulfill the daily requirements of both new and seasoned users. This research emphasizes critical areas such as comfort, vision quality, and overall performance—demonstrating that modern lenses are attuned to user needs.

Posters exhibited at the congress will delve into the perspectives of eye care professionals and consumers regarding remote eye care, revealing specific motivations and decision-making factors for both novice and experienced contact lens wearers. The findings indicate promising opportunities for engaging more individuals in trying and adopting contact lenses.

Multifocal Contact Lenses

In response to the growing demand for multifocal contact lenses, CooperVision’s additional research presented at NCC will include three studies exploring the adaptation process for presbyopia patients. Early findings indicate opportunities for more proactive management in fitting patients experiencing early presbyopia, aligning with adaptation guideline recommendations. Furthermore, these studies demonstrate promising user satisfaction rates among those transitioning from hydrogel lenses to silicone hydrogel multifocals.

This wealth of new information will be critical for eye care providers, equipping them with the knowledge to support patients from their first contact lens experience all the way through to presbyopia management.

Join the Conversation

NCC is a biennial event that attracts thousands of vision care professionals, educators, researchers, and manufacturers from the Netherlands, Europe, and around the globe. For further details on the 2026 congress sessions and speakers, you can visit contactlenscongress.com.

CooperVision, a division of CooperCompanies (NASDAQ: COO), has made a name for itself as a global manufacturer of contact lenses, producing an extensive array of daily, bi-weekly, and monthly disposable lenses. With a focus on innovation, they tackle complex vision challenges, including astigmatism and presbyopia, striving to deliver optimal solutions tailored to the needs of their customers.

For more information on CooperVision, including their commitment to developing advanced lens technology, visit coopervision.com.